Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Change Of Guard At Quintiles India As Company Continues Aggressive Asia Efforts With Samsung Deal

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Quintiles Transnational Corp.'s India CEO Ferzaan Engineer will step down after serving the multinational contract research organization since its inception in India more than 13 years ago

You may also be interested in...



Quintiles Draws Curtain On Phase I India Unit As External Business Environment Gets Challenging

The leading CRO shutters its Phase I unit in Hyderabad inaugurated only two years ago. The decision signifies the tough regulatory challenges global companies are facing in India.

Quintiles Draws Curtain On Phase I India Unit As External Business Environment Gets Challenging

The leading CRO shutters its Phase I unit in Hyderabad inaugurated only two years ago. The decision signifies the tough regulatory challenges global companies are facing in India.

Quintiles Moves Fast In China With Dalian Center and Shanghai Lab As Local Studies Explode

After launching its local entity Kun Tuo in China, CRO Quintiles accelerated its pace in China with the opening of a center of excellence in Dalian and a partnership with Shanghai Clinical Research Center.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel